Expert Ratings for AVITA Medical
Portfolio Pulse from Benzinga Insights
AVITA Medical (NASDAQ:RCEL) has received 7 bullish ratings from analysts in the last quarter, with an average price target of $28.43, indicating a potential upside from the current price of $16.49. The average price target has increased by 12.37% over the past month.
August 22, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are bullish on AVITA Medical, indicating a potential upside for the stock.
The bullish sentiment from analysts, indicated by 7 positive ratings and an average price target that is significantly higher than the current price, suggests a potential upside for AVITA Medical's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100